Lan Wang

Title: Innovations by Lan Wang in Urine-Modified Nucleoside Detection

Introduction

Lan Wang is an accomplished inventor based in Fujian, China. He has made significant contributions to the field of medical diagnostics, particularly in the detection of urine-modified nucleosides. His innovative approach utilizes advanced spectroscopy techniques to enhance diagnostic accuracy for cancer detection.

Latest Patents

Lan Wang holds a patent for a "Detection and analysis method for urine-modified nucleoside based on surface-enhanced resonance Raman spectroscopy." This invention presents a novel method for extracting tumor marker modified nucleosides from urine samples of both normal individuals and cancer patients. The technique employs borophenylic acid gel for specificity in extraction, while Au colloid serves as an enhancing substrate for detecting SERRS signals. The statistical analysis is performed using PLS-DA algorithms, which help establish a diagnostic model for identifying the nature of the urine-modified nucleoside. The model boasts impressive metrics, including a specificity of 96.9%, sensitivity of 98.2%, and accuracy of 97.6%. This rapid and objective detection method provides crucial insights for medical professionals in diagnosing esophagus cancer.

Career Highlights

Lan Wang is affiliated with Fujian Normal University, where he continues to advance research in medical diagnostics. His work has garnered attention for its potential impact on cancer detection and patient care.

Collaborations

Lan Wang collaborates with notable colleagues, including Shangyuan Feng and Zuci Zheng, who contribute to his research endeavors.

Conclusion

Lan Wang's innovative methods in urine-modified nucleoside detection represent a significant advancement in cancer diagnostics. His contributions are poised to enhance the accuracy and efficiency of medical diagnoses, ultimately benefiting patient outcomes.